Abegaill

Rotterdam, Netherlands Founded: 2017 • Age: 9 yrs
Abegaill B.V. is focused on developing ductoscopy medical devices.

About Abegaill

Abegaill is a company based in Rotterdam (Netherlands) founded in 2017. It operates as a HealthTech. Abegaill offers products and services including Ductoscopy Devices. Abegaill operates in a competitive market with competitors including Cianna Medical, Elucent Medical, KUB Technologies, SenoRx and Health Beacons, among others.

  • Headquarter Rotterdam, Netherlands
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website abegaill.com
  • Legal Name Abegaill B.V.
Key Metrics

Products & Services of Abegaill

Abegaill offers a comprehensive portfolio of products and services, including Ductoscopy Devices.

Ductoscopy Devices
Medical Devices

Devices for ductoscopy to treat breast disease are developed.

Funding Insights of Abegaill

  • Total Rounds 1
  • Investors Count 2

All 1 funding rounds of Abegaill with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Dec 2017–Seed–Swanbridge Capital, Leander Healthcare
–
Valuation history

2 investors in total: 2 institutional.

Investors in Abegaill

Abegaill has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Swanbridge Capital and Leander Healthcare.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
-
–swanbridgecapital.nl-
Leander Healthcare is engaged in distributing medical devices in Benelux.
2009leanderhealthcare.comVleuten, Netherlands
Premium access

Investor details for Abegaill

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Abegaill

1 people are tracked at Abegaill (1 in leadership).

NameRoleGroup
Edwin Leander
CEOLeadership
Premium access

Complete people profiles for Abegaill

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Abegaill

2 dated milestones of Abegaill, from founding to its latest funding, stage changes and deals.

  1. Founded Abegaill is founded.
  2. Funding First funding round.

Competitors of Abegaill

Abegaill operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cianna Medical, Elucent Medical, KUB Technologies, SenoRx and Health Beacons, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
ciannamedical.com2007Aliso Viejo, United States$49.5M2,709
Breast brachytherapy devices and surgical guidance systems are developed.
elucentmedical.com2014Brookfield, United States–11
Develops smart surgical guidance systems with in-body spatial intelligence for accuracy.
kubtec.com2005Stratford, United States–51
Provides medical devices for specimen imaging and gamma probes in healthcare facilities.
senorx.com1998Irvine, United States––
Minimally Invasive devices for breast cancer treatment & diagnosis
healthbeacons.com2008Concord, United States–4,165
Provides an RFID localization system for effective cancer treatment.
polumiros.com2016Toronto, Canada––
Regenerative biomaterials for immunomodulatory tissue healing are developed.
rogerssciences.com2010Boston, United States$500,000–
Offers continuous low irradiance photodynamic therapy for breast cancer treatment.
medi-future.com2006Seongnam-si, South Korea––
Medical devices for breast diagnostics and bone care are produced.
scionmedtech.com2011Shanghai, China––
Creates innovative technologies for breast biopsy devices.
Premium access

Detailed competitors of Abegaill

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Similar companies to Abegaill

10 companies that operate in the same segment as Abegaill (Women's Health & Fertility), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Internet first brand offering wearable breast pumps
2013London, England, United KingdomUSD 157.63 M––
Silicone-filled breast and body shaping implants are designed and manufactured.
2010Alajuela, Alajuela, Costa RicaUSD 121 MUSD 211.08 M1,020
Immunotherapeutics for cancer and other diseases are developed.
2008Mainz, Rhineland-palatinate, GermanyUSD 805.99 MUSD 3.24 B6,770
Developer of cell-free DNA testing for oncology, women’s health, and organ health
2004Redwood City, California, United StatesUSD 152.1 MUSD 2.31 B4,430
Therapeutics for women's healthcare are developed and offered.
1997Princeton, New Jersey, United StatesUSD 124.07 MUSD 19.59 M–
Provider of cell-free cancer liquid biopsy test
2015San Francisco, California, United StatesUSD 388.62 M–47
Developer of immune cell therapies
2019San Francisco, California, United StatesUSD 631.16 M–178
Platform for breast ultrasound imaging
2010Plymouth, Massachusetts, United StatesUSD 136.54 M––
Silicone breast implants are developed for reconstruction and aesthetic surgery.
2007Dublin, IrelandUSD 232.81 M––
A minimally invasive ablation system for uterine fibroids is developed.
2005Redwood City, California, United StatesUSD 282.54 M–92
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Abegaill

Abegaill was founded in 2017.

Abegaill is headquartered in Rotterdam, Netherlands. It is registered at Rotterdam, South Holland, Netherlands.

Edwin Leander is the current CEO of Abegaill.

Abegaill B.V. is engaged in the development of medical devices specialized in ductoscopy. The company is aimed at treating pre-malignant and malignant breast diseases through innovative solutions. Based in Rotterdam, Netherlands, it operates within the healthcare sector, focusing on advancing diagnostic and treatment technologies for breast health.

Abegaill's top competitors include Cianna Medical, SenoRx and Polumiros.

Abegaill offers Ductoscopy Devices.

Abegaill has 2 investors. Key investors include Swanbridge Capital, and Leander Healthcare.

Abegaill operates through Abegaill B.V..

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available